Clinical Trials Logo

Stress Disorders, Post-Traumatic clinical trials

View clinical trials related to Stress Disorders, Post-Traumatic.

Filter by:

NCT ID: NCT02545192 Not yet recruiting - Clinical trials for Post Traumatic Stress Disorder

A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments

LFMS in PTSD
Start date: September 2016
Phase: Phase 1
Study type: Interventional

The investigators propose to make the first observations of LFMS treating a population of subjects with PTSD. A positive outcome for this study could translate directly into a new treatment modality for symptoms of PTSD in both acute and chronic situations. The investigator's goal is to demonstrate the safety and efficacy of LFMS as a possible aid in the treatment of PTSD.

NCT ID: NCT02544971 Active, not recruiting - PTSD Clinical Trials

Neurofeedback Therapeutic Intervention For Post-Traumatic Stress Disorder Patients Compared To Treatment As Usual

NFTIP
Start date: April 2016
Phase: N/A
Study type: Interventional

Post-traumatic stress disorder (PTSD) is a common debilitating disorder that affects many individuals exposed to aversive events. The severity of PTSD symptoms is positively correlated with amygdala activation. More severe PTSD symptoms following exposure to stressful events, are associated with amygdala hyper-responsivity prior to exposure. A possible intervention for PTSD is Neurofeedback (NF) - a treatment method based on learned self-modulation of neural activity in response to feedback of neural signal. Previous work in our lab established a NF training procedure that utilizes the temporal abilities of EEG with the spatial advantages of fMRI. Further work based on this method using the amygdala BOLD signal (EEG-finger-print, EFP) has demonstrated a potential for improving the ability to self-regulate amygdala activity and to improve emotional regulation in a healthy population. The current study aims to investigate the potential of this method as a therapeutic intervention for PTSD.

NCT ID: NCT02542709 Recruiting - Clinical trials for Post-traumatic Stress Disorder

The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder

Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of this trial is to study the effect of noninvasive brain stimulation in adults with post-traumatic stress disorder.

NCT ID: NCT02538601 Completed - Clinical trials for Post Traumatic Stress Disorder

Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster

Start date: February 2012
Phase: N/A
Study type: Interventional

The purpose of this study was to test the efficacy of a CBT-based smoking cessation treatment enhanced with transdiagnostic skills for the management of anxiety and fear-based avoidance behaviors (CBT-A) relative to a standard CBT-based smoking cessation treatment (CBT-S) for smokers with elevated PTSD symptoms who were exposed to the 9/11 World Trade Center disaster. The investigators hypothesized that the CBT-A treatment would yield more favorable outcomes with regard to smoking abstinence as well as improvements in PTSD and respiratory symptoms over a 6-month follow-up period.

NCT ID: NCT02537678 Completed - Clinical trials for Posttraumatic Stress Disorder

Stepped Care for Children After Trauma: Optimizing Treatment

Start date: August 1, 2015
Phase: N/A
Study type: Interventional

Children who are exposed to traumatic events are at risk for developing PTSD and other mental health problems. Although effective treatments for childhood PTSD exist, service delivery approaches that are more accessible, efficient, and cost-effective are needed to improve access to evidence-based treatment. The proposed study furthers our pilot work and evaluates an innovative Stepped Care Trauma-Focused Cognitive Behavioral Therapy designed to optimize treatment in community settings and improve the value and efficiency of trauma-focused treatment for children compared to existing approaches, thereby reducing childhood PTSD and related societal impacts and costs.

NCT ID: NCT02520726 Terminated - Clinical trials for Post-traumatic Stress Disorder

PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims

Start date: September 2013
Phase: Phase 4
Study type: Interventional

This is a randomized, double-blind, placebo-controlled study to determine whether administration of sertraline to patients who exhibit acute stress disorder secondary to severe burns can contribute to the prevention of post-traumatic stress disorder (PTSD).

NCT ID: NCT02519725 Completed - Clinical trials for Stress Disorders Post Traumatic

Impact of an ICU Diary on the Well-being of Patients and Families. A Prospective Multicenter Mixed Study

ICU-diary
Start date: June 11, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the influence of an ICU diary implemented during the ICU stay on the psychological well-being of patients and families after ICU discharge.

NCT ID: NCT02519296 Active, not recruiting - Clinical trials for Stress Disorders, Post-Traumatic

A fMRI Study of the Treatment of Danish Veterans With PTSD With Prolonged Exposure Therapy

Start date: January 2016
Phase: N/A
Study type: Interventional

In this article, the investigators report the design and protocol of a functional magnetic resonance imaging study (fMRI) of the treatment of Danish veterans with PTSD with Prolonged Exposure Therapy (PE). In total 30 Danish veterans will be recruited, who meet the ICD-10 diagnostic criteria for PTSD, and treated with PE. A group of controls will be recruited consisting of age-appropriate same sex veterans who have participated in international missions similar to the patient group

NCT ID: NCT02517723 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder

Start date: April 2014
Phase: N/A
Study type: Interventional

Narrative Exposure Therapy (NET) is an evidence-based trauma-focussed treatment, suitable for survivors of prolonged and repeated exposure to traumatic stress and childhood adversity. Patients with Borderline Personality Disorder (BPD) often suffer from a comorbid Posttraumatic Stress Disorder (PTSD) caused by multiple traumatic events. Therapeutic aims are the reduction of PTSD-Symptoms in these patients via activation of associative neural networks related to traumatic experiences and habituation of fear and the placement of traumatic experiences in a reconstructed, detailed and consistent autobiography. This practice enables the processing of and coping with painful memories and the construction of clear contingencies of dangerous and safe conditions, generally leading to significant emotional recovery. The investigators assume that using NET the reduction of PTSD symptom severity is greater compared to treatment by Dialectical-Behavioral Therapy (DBT).

NCT ID: NCT02517424 Completed - Clinical trials for Posttraumatic Stress Disorder

Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder

Start date: February 7, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of vaporized cannabis in participants with chronic, treatment-resistant posttraumatic stress disorder.